Hyderabad-based pharmaceutical major Dr Reddy's Laboratories Ltd. launched orally disintegrating Lamotrigine tablets in the U.S. market.
The tablet is a generic equivalent of Lamictal ODT developed by GlaxoSmithKline group, the company said in a press release.
The drug is primarily used for treating epileptic seizures, mood swings in bipolar disorders and sometimes for cluster headaches and migraines.
The Lamictal ODT brand and generic had sales of around $65.5 million per annum in the U.S., as of July 2016. The generic version has been launched by Dr Reddy's in four variants of 25mg, 50mg, 100mg and 200mg, the release said.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
.jpg?im=FeatureCrop,algorithm=dnn,width=350)